The tempting business of smart drugs: A concrete health risk Schillaci DR, Caligara M, Di Candia D, Santagata M, Morini O, Lodi F Cattedra di Medicina Legale -Università degli Studi di Milano-Bicocca, Italy The so-called smart-drugs, plant-based substances used for centuries by diverse populations especially of Central America in strict ritualized shamanic context thanks to their psychotropic effects, from the nine- ties have had wide diffusion across Europe. In Italy smart-drugs business, bypassing traditional clandestine labs and illicit channels, was possible by their availability in smart-shops appeared in Milan and Rome and moreover exploiting the ever-expan- ding internet system. Via the Internet avid surfers have found trouble- free accessibility to smart-drugs at low cost with the advantage of diffi- culties in police control, anonymity and lack of regulations, too. In Italy, between 2001-2003, Postal Police has seized more than five hun- dred parcels containing suspicious botanical species and tablets sent af- ter on-line purchases by a known Dutch Internet site to Italian buyers. The authors hereby present the results of toxicological analysis on these findings (1167), with evidence of active principles ascribable to different smart-drugs: salvinorine in Salvia divinorum; LSA (ergine) in seeds of Rivea corymbosa, Ipomea violacea, Argyreia nervosa, harmine and harmaline in Peganum harmala, mescaline in Lophophora Williamsii, psilocybin/psilocin in Copelandia Cyanescens, Psilocybe Tampanensis, Psilocybe Cubensis, Philosophers Stones, ephedrine and yohimbine in several pharmaceutical products. Considering smart-drugs an unknown hazard and a potential emer- ging drug of abuse we give a general overview of the possible psychoac- tive effects of the most widely used smart drugs in their various forms of intake and their possible harms on man. Furthermore we illustrate the most recent trade restrictions adopted in Italy to limit their diffusion via the Internet.

The tempting business of smart drugs: A concrete health risk / D. Schillaci, M. Caligara, D. Di Candia, M. Santagata, O. Morini, F. Lodi. ((Intervento presentato al 6. convegno International Symposium on Advances in Legal Medicine (ISALM) Hamburg : 19th–24th September tenutosi a Hamburg nel 2005.

The tempting business of smart drugs: A concrete health risk

M. Caligara;D. Di Candia;
2005-09-19

Abstract

The tempting business of smart drugs: A concrete health risk Schillaci DR, Caligara M, Di Candia D, Santagata M, Morini O, Lodi F Cattedra di Medicina Legale -Università degli Studi di Milano-Bicocca, Italy The so-called smart-drugs, plant-based substances used for centuries by diverse populations especially of Central America in strict ritualized shamanic context thanks to their psychotropic effects, from the nine- ties have had wide diffusion across Europe. In Italy smart-drugs business, bypassing traditional clandestine labs and illicit channels, was possible by their availability in smart-shops appeared in Milan and Rome and moreover exploiting the ever-expan- ding internet system. Via the Internet avid surfers have found trouble- free accessibility to smart-drugs at low cost with the advantage of diffi- culties in police control, anonymity and lack of regulations, too. In Italy, between 2001-2003, Postal Police has seized more than five hun- dred parcels containing suspicious botanical species and tablets sent af- ter on-line purchases by a known Dutch Internet site to Italian buyers. The authors hereby present the results of toxicological analysis on these findings (1167), with evidence of active principles ascribable to different smart-drugs: salvinorine in Salvia divinorum; LSA (ergine) in seeds of Rivea corymbosa, Ipomea violacea, Argyreia nervosa, harmine and harmaline in Peganum harmala, mescaline in Lophophora Williamsii, psilocybin/psilocin in Copelandia Cyanescens, Psilocybe Tampanensis, Psilocybe Cubensis, Philosophers Stones, ephedrine and yohimbine in several pharmaceutical products. Considering smart-drugs an unknown hazard and a potential emer- ging drug of abuse we give a general overview of the possible psychoac- tive effects of the most widely used smart drugs in their various forms of intake and their possible harms on man. Furthermore we illustrate the most recent trade restrictions adopted in Italy to limit their diffusion via the Internet.
Settore MED/43 - Medicina Legale
The tempting business of smart drugs: A concrete health risk / D. Schillaci, M. Caligara, D. Di Candia, M. Santagata, O. Morini, F. Lodi. ((Intervento presentato al 6. convegno International Symposium on Advances in Legal Medicine (ISALM) Hamburg : 19th–24th September tenutosi a Hamburg nel 2005.
Conference Object
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/866576
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact